Alpha Tau Medical (DRTS)
(Delayed Data from NSDQ)
$2.10 USD
+0.01 (0.52%)
Updated Jul 24, 2024 02:28 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Balance Sheet
Fiscal Year End for Alpha Tau Medical Ltd falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 82 | 105 | 32 | 0 | 0 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 4 | 1 | 1 | 0 | 0 |
Total Current Assets | 86 | 106 | 33 | 0 | 0 |
Net Property & Equipment | 13 | 7 | 8 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 2 | 0 | 0 |
Total Assets | 107 | 120 | 42 | 0 | 0 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 1 | 1 | 0 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 2 | 3 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 7 | 4 | 4 | 0 | 0 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 6 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 6 | 19 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 54 | 0 | 0 |
Total Liabilities | 23 | 14 | 77 | 0 | 0 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 200 | 192 | 18 | 0 | 0 |
Retained Earnings | -116 | -87 | -53 | 0 | 0 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 84 | 106 | -35 | 0 | 0 |
Total Liabilities & Shareholder's Equity | 107 | 120 | 42 | 0 | 0 |
Total Common Equity | 84 | 106 | -35 | 0 | 0 |
Shares Outstanding | 69.60 | 66.90 | 40.50 | 0.40 | NA |
Book Value Per Share | 1.21 | 1.58 | -0.86 | 0.05 | 0.00 |
Fiscal Year End for Alpha Tau Medical Ltd falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 78 | 82 | 87 | 94 |
Receivables | NA | 0 | 0 | NA | NA |
Notes Receivable | NA | 0 | 0 | NA | NA |
Inventories | NA | 0 | 0 | NA | NA |
Other Current Assets | NA | 4 | 4 | 4 | 2 |
Total Current Assets | NA | 81 | 86 | 91 | 96 |
Net Property & Equipment | NA | 13 | 13 | 8 | 8 |
Investments & Advances | NA | 0 | 0 | NA | NA |
Other Non-Current Assets | NA | 0 | 0 | NA | NA |
Deferred Charges | NA | 0 | 0 | NA | NA |
Intangibles | NA | 0 | 0 | NA | NA |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 102 | 107 | 107 | 111 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | NA | NA |
Accounts Payable | NA | 2 | 3 | 2 | 2 |
Current Portion Long-Term Debt | NA | 0 | 0 | NA | NA |
Current Portion Capital Leases | NA | 0 | 0 | NA | NA |
Accrued Expenses | NA | 3 | 3 | 3 | NA |
Income Taxes Payable | NA | 0 | 0 | NA | NA |
Other Current Liabilities | NA | 0 | 0 | NA | 3 |
Total Current Liabilities | NA | 7 | 7 | 6 | 5 |
Mortgages | NA | 0 | 0 | NA | NA |
Deferred Taxes/Income | NA | 0 | 0 | NA | NA |
Convertible Debt | NA | 0 | 0 | NA | NA |
Long-Term Debt | NA | 6 | 6 | NA | NA |
Non-Current Capital Leases | NA | 0 | 0 | NA | NA |
Other Non-Current Liabilities | NA | 4 | 5 | 8 | |
Minority Interest (Liabilities) | NA | 0 | 0 | NA | NA |
Total Liabilities | NA | 23 | 23 | 17 | 19 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | NA | NA |
Common Stock (Par) | NA | 0 | 0 | NA | NA |
Capital Surplus | NA | 203 | 200 | 198 | 196 |
Retained Earnings | NA | -124 | -116 | -108 | -103 |
Other Equity | NA | 0 | 0 | NA | NA |
Treasury Stock | NA | 0 | 0 | NA | NA |
Total Shareholder's Equity | NA | 79 | 84 | 90 | 93 |
Total Liabilities & Shareholder's Equity | NA | 102 | 107 | 107 | 111 |
Total Common Equity | 0 | 79 | 84 | 100,089 | 100,092 |
Shares Outstanding | 69.60 | 69.60 | 69.60 | 69.30 | 69.30 |
Book Value Per Share | 0.00 | 1.14 | 1.21 | 1,444.28 | 1,444.32 |